APA (7th ed.) Citation

Varbanova, V., Mihaylova, S., Naumova, E., & Mihaylova, A. P. (2019, November). Certain Killer Immunoglobulin-Like Receptor (KIR)/KIR HLA Class I Ligand Genotypes Influence Natural Killer Antitumor Activity in Myelogenous Leukemia but Not in Acute Lymphoblastic Leukemia: A Case Control Leukemia Association Study. Turkish Journal of Hematology.

Chicago Style (17th ed.) Citation

Varbanova, Viktoria, Snejina Mihaylova, Elissaveta Naumova, and Anastasiya Petrova Mihaylova. "Certain Killer Immunoglobulin-Like Receptor (KIR)/KIR HLA Class I Ligand Genotypes Influence Natural Killer Antitumor Activity in Myelogenous Leukemia but Not in Acute Lymphoblastic Leukemia: A Case Control Leukemia Association Study." Turkish Journal of Hematology Nov. 2019.

MLA (9th ed.) Citation

Varbanova, Viktoria, et al. "Certain Killer Immunoglobulin-Like Receptor (KIR)/KIR HLA Class I Ligand Genotypes Influence Natural Killer Antitumor Activity in Myelogenous Leukemia but Not in Acute Lymphoblastic Leukemia: A Case Control Leukemia Association Study." Turkish Journal of Hematology, Nov. 2019.